Thirty six percent of patients with progressive myoclonic epilepsy (including NCL1, NCL2, Melas disease and Leigh disease), had normal imaging; 20.4% of patients had brain atrophy; 25.1% had white matter involvement, and the rest of patients had involvement in different regions. Here, CAPN3 is linked to progressive myoclonus epilepsy.